BeOne Medicines
ONC
#755
Rank
โ‚น3.098 T
Marketcap
โ‚น27,881
Share price
-0.48%
Change (1 day)
29.03%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Earnings for BeOne Medicines (ONC)

Earnings in 2025 (TTM): โ‚น42.09 Billion

According to BeOne Medicines's latest financial reports the company's current earnings are โ‚น5.34 Billion. , an increase over its 2024 earnings that were of -โ‚น53.92 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BeOne Medicines from 2015 to 2025

Annual earnings

Year Earnings Change
2025 โ‚น45.07 B-183.61%
2024 -โ‚น53.92 Billion-52.95%
2023 -โ‚น114.59 Billion-32.52%
2022 -โ‚น169.81 Billion24.39%
2021 -โ‚น136.51 Billion-13.21%
2020 -โ‚น157.29 Billion72.69%
2019 -โ‚น91.08 Billion36.01%
2018 -โ‚น66.97 Billion616.83%
2017 -โ‚น9.35 Billion-15.24%
2016 -โ‚น11.03 Billion107.91%
2015 -โ‚น5.31 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚น15.14 Billion-133.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚น1.73 Billion-103.82%๐Ÿ‡บ๐Ÿ‡ธ USA